- Country: USA
- Summary: Discovery And Development Of Novel Therapeutics For Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed)
- UST Ref No: 107627673
- Deadline: 28 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-AI-24-065
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Purpose Of This Notice Of Funding Opportunity (Nofo) Is To Support Milestone-Driven, Early-Stage Translational Research Focused On Drug Discovery And Development Of Novel Therapeutics Against Select Fungal Pathogens Including: Candida Species, Specifically Candida Auris; Aspergillus Fumigatus; Coccidioides; And Mucorales. This Nofo Will Use A Milestone-Driven, Biphasic Award Mechanism. Transition To The R33 Phase Will Depend On The Successful Completion Of Specific Milestones During The R21 Phase.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDiscovery And Development Of Novel Therapeutics For Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Discovery And Development Of Novel Therapeutics For Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 107627673 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
